A Phase I, Randomized, Double-blind, Placebo-controlled, Single-center Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Including the Effect of Food, and Pharmacodynamics of Single and Multiple Ascending Oral Doses of GLPG3312, in Adult, Healthy Subjects
Latest Information Update: 16 Jul 2024
At a glance
Most Recent Events
- 18 Mar 2020 Status changed from recruiting to completed.
- 26 Sep 2019 Planned End Date changed from 1 Sep 2019 to 1 Mar 2020.
- 26 Sep 2019 Planned primary completion date changed from 1 Sep 2019 to 1 Mar 2020.